Sep 17, 2020 / 07:30PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst
I'm Tejas Savant, and I cover the life sciences and diagnostics sector here at Morgan Stanley. Delighted to have Personalis join us today, and representing the company are John West, CEO; and Aaron Tachibana, CFO. Welcome, gents.
Before we get started, I have a quick disclaimer I need to read through. So please note that the webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. The webcast is not for members of the press, so if you're with the press, please disconnect and reach out separately. For important disclosures, please see morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales rep.
Questions and Answers:
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity AnalystSo with that said, John, welcome once again. Maybe just to set the stage, could you share your perspective on the evolution of Personalis over the last 5 years or so? I mean maybe even before -- I mean,